|
ÆÄ·º¼¿ ÄÚ¸®¾Æ |
ÆĶô¼¿ ÄÚ¸®¾Æ-CRA/Sr.CRA ¸ðÁý
¼¿ï °³²±¸ | ´ëÇÐ(4³â) ÀçÇÐ |
CRA/ÀÓ»óPM/CRM |
1³â¡è |
ä¿ë½Ã |
02.14 |
|
|
°æºÏ´ëÇб³º´¿ø ÀÓ»ó½ÃÇè¼¾ÅÍ |
°æºÏ´ëÇк´¿ø ÀÓ»ó½ÃÇè¼¾ÅÍ ºÐ¼®½Ç ¿¬±¸¿ø
´ë±¸ ÀüÁö¿ª | ´ëÇÐ(4³â) ÀçÇÐ |
CRA/ÀÓ»óPM/CRM |
°æ·Â¹«°ü |
ä¿ë½Ã |
01.31 |
|
|
(ÁÖ) ÀÌÅ¥½º¾ØÀÚ·ç ½Å¾à°³¹ß¿¬±¸¼Ò |
(ÁÖ) ÀÌÅ¥½º¾ØÀÚ·ç °ø½Ã, IR, °æ¿µ±âȹ ¹× À繫 °æ¿µ»ç¿ø¸ð
°æ±â ¼º³²½Ã ºÐ´ç±¸ | ´ëÇÐ(4³â) ÀçÇÐ |
À繫/ȸ°è/IR/ÀÚ±Ý/°¨»ç |
3³â¡è |
ä¿ë½Ã |
01.10 |
|
|
(ÁÖ)ÀÌÈ¿¹ÙÀÌ¿À½ÎÀ̾𽺠|
Çмú ¸¶ÄÉÆÃ
¼¿ï ¼ÛÆı¸, ±¤ÁÖ ±¤»ê±¸ | ´ëÇÐ(4³â) ÀçÇÐ |
¸¶ÄÉÆÃ/±âȹ/±³À° |
°æ·Â¹«°ü |
ä¿ë½Ã |
04.04 |
|
|
ÆÄ·º¼¿ ÄÚ¸®¾Æ |
Clinical Lead (for Dedicated CRA) ¸ðÁý -ÆĶô¼¿ÄÚ¸®¾Æ
¼¿ï °³²±¸ | ´ëÇÐ(4³â) ÀçÇÐ |
CRA/ÀÓ»óPM/CRM |
1³â¡è |
ä¿ë½Ã |
07.16 |
|
|
ÆĶó°ïÄÁ¼³Æà |
¿Ü±¹°è Á¦¾àȸ»ç Regional CRM(¾Æ½Ã¾Æ Áö¿ª ÀÓ»ó´ã´ç ¸Å´ÏÀú
¼¿ï ÀüÁö¿ª | ´ëÇÐ(4³â) ÀçÇÐ |
CRA/ÀÓ»óPM/CRM |
5³â¡è |
ä¿ë½Ã |
05.31 |
|
|
IMS Health Korea |
Consultant ¸ðÁý
¼¿ï °³²±¸ | ´ëÇÐ(4³â) ÀçÇÐ |
¸¶ÄÉÆÃ/±âȹ/±³À° |
°æ·Â¹«°ü |
»ó½Ãä¿ë |
09.12 |
|
|
PPD Development Pte. Ltd. |
SCRA ¹× CRA II ä¿ë
¼¿ï °³²±¸ | ´ëÇÐ(4³â) ÀçÇÐ |
CRA/ÀÓ»óPM/CRM |
2³â¡è |
ä¿ë½Ã |
06.07 |
|
|
ÆÄ·º¼¿ ÄÚ¸®¾Æ |
ÆĶô¼¿ ÄÚ¸®¾Æ -Clinical Lead (CPS Department)
¼¿ï °³²±¸ | ´ëÇÐ(4³â) ÀçÇÐ |
CRA/ÀÓ»óPM/CRM |
4³â¡è |
ä¿ë½Ã |
08.08 |
|
|
BMM KOREA |
ȯÀÚ±³À°ÇÁ·Î±×·¥À» ±âȹ.¸¶ÄÉÆôã´ç ÆÀÀ屸ÀÎ
¼¿ï ¸¶Æ÷±¸ | ´ëÇÐ(4³â) ÀçÇÐ |
¸¶ÄÉÆÃ/±âȹ/±³À° |
3³â¡è |
ä¿ë½Ã |
03.21 |
|
|
(ÁÖ)¾¾¾ØÆÊ |
¿¬±¸¼Ò Ã¥ÀÓ¿¬±¸¿ø ¹× ¿¬±¸¿ø ¸ðÁý
¼¿ï ¼´ë¹®±¸ | ´ëÇÐ(4³â) ÀçÇÐ |
¿¬±¸/¿¬±¸±âȹ |
5³â¡è |
ä¿ë½Ã |
05.20 |
|
|
ÁÖ)ÈÞÅÛ |
HUTEM ¸¶ÄÉÆÃ(PM) ¸ðÁý
°æ±â °í¾ç½Ã ´ö¾ç±¸ | ´ëÇÐ(4³â) ÀçÇÐ |
¸¶ÄÉÆÃ/±âȹ/±³À° |
°æ·Â¹«°ü |
ä¿ë½Ã |
12.19 |
|
|
(ÁÖ)¸Þµð½êÀÌ |
°æ±â ÀÇÁ¤ºÎ½Ã | ´ëÇÐ(4³â) ÀçÇÐ |
¿¬±¸/¿¬±¸±âȹ |
°æ·Â¹«°ü |
ä¿ë½Ã |
08.19 |
|
|
À⽺Å×À̼ÇÄÚ¸®¾Æ |
¶óÀ̼¾½ÌÆÀ ÀϺ»Áö¿ª ´ã´ç - ¸ÞÀÌÀú Á¦¾à»ç
¼¿ï ÀüÁö¿ª | ´ëÇÐ(4³â) ÀçÇÐ |
¶óÀ̼¾½ºIn/Out |
2³â¡è |
ä¿ë½Ã |
07.16 |
|
|
Æĵð¾ÆÄÚ¸®¾Æ |
Marketing Specialist
¼¿ï ±Ýõ±¸ | ´ëÇÐ(4³â) ÀçÇÐ |
Á¦¾à¿µ¾÷/ÀÇ·á±â¿µ¾÷ |
½ÅÀÔ |
ä¿ë½Ã |
02.11 |
|